278 related articles for article (PubMed ID: 29503867)
1. Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.
Wang G; Chow RD; Ye L; Guzman CD; Dai X; Dong MB; Zhang F; Sharp PA; Platt RJ; Chen S
Sci Adv; 2018 Feb; 4(2):eaao5508. PubMed ID: 29503867
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-mediated direct mutation of cancer genes in the mouse liver.
Xue W; Chen S; Yin H; Tammela T; Papagiannakopoulos T; Joshi NS; Cai W; Yang G; Bronson R; Crowley DG; Zhang F; Anderson DG; Sharp PA; Jacks T
Nature; 2014 Oct; 514(7522):380-4. PubMed ID: 25119044
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
Wangensteen KJ; Wang YJ; Dou Z; Wang AW; Mosleh-Shirazi E; Horlbeck MA; Gilbert LA; Weissman JS; Berger SL; Kaestner KH
Hepatology; 2018 Aug; 68(2):663-676. PubMed ID: 29091290
[TBL] [Abstract][Full Text] [Related]
5. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
6. Cancer CRISPR Screens In Vivo.
Chow RD; Chen S
Trends Cancer; 2018 May; 4(5):349-358. PubMed ID: 29709259
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
8. CRISPR Libraries and Screening.
Poirier JT
Prog Mol Biol Transl Sci; 2017; 152():69-82. PubMed ID: 29150005
[TBL] [Abstract][Full Text] [Related]
9. Genetic screens and functional genomics using CRISPR/Cas9 technology.
Hartenian E; Doench JG
FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9 knockin mice for genome editing and cancer modeling.
Platt RJ; Chen S; Zhou Y; Yim MJ; Swiech L; Kempton HR; Dahlman JE; Parnas O; Eisenhaure TM; Jovanovic M; Graham DB; Jhunjhunwala S; Heidenreich M; Xavier RJ; Langer R; Anderson DG; Hacohen N; Regev A; Feng G; Sharp PA; Zhang F
Cell; 2014 Oct; 159(2):440-55. PubMed ID: 25263330
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 and cancer targets: future possibilities and present challenges.
White MK; Khalili K
Oncotarget; 2016 Mar; 7(11):12305-17. PubMed ID: 26840090
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
Peng J; Zhou Y; Zhu S; Wei W
FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
[TBL] [Abstract][Full Text] [Related]
13. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
14. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
Kennedy EM; Cullen BR
Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
[TBL] [Abstract][Full Text] [Related]
15. Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo.
Codina A; Renauer PA; Wang G; Chow RD; Park JJ; Ye H; Zhang K; Dong MB; Gassaway B; Ye L; Errami Y; Shen L; Chang A; Jain D; Herbst RS; Bosenberg M; Rinehart J; Fan R; Chen S
Cell Syst; 2019 Feb; 8(2):136-151.e7. PubMed ID: 30797773
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
[TBL] [Abstract][Full Text] [Related]
17. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.
Thomsen EA; Mikkelsen JG
Methods Mol Biol; 2019; 1961():343-357. PubMed ID: 30912056
[TBL] [Abstract][Full Text] [Related]
19. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids.
Michels BE; Mosa MH; Streibl BI; Zhan T; Menche C; Abou-El-Ardat K; Darvishi T; Członka E; Wagner S; Winter J; Medyouf H; Boutros M; Farin HF
Cell Stem Cell; 2020 May; 26(5):782-792.e7. PubMed ID: 32348727
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.
Feng X; Tang M; Dede M; Su D; Pei G; Jiang D; Wang C; Chen Z; Li M; Nie L; Xiong Y; Li S; Park JM; Zhang H; Huang M; Szymonowicz K; Zhao Z; Hart T; Chen J
Sci Adv; 2022 May; 8(19):eabm6638. PubMed ID: 35559673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
